![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » InBios International Gains EUA for COVID-19 Antibody Test
InBios International Gains EUA for COVID-19 Antibody Test
Seattle, Wash.-based Inbios International has received an Emergency Use Authorization (EUA) from the FDA for its SCoV-2 Detect Neutralizing Ab ELISA test.
The test, which detects neutralizing antibodies to the SARS-CoV-2 virus from human serum and plasma, is designed to identify individuals who have had an adaptive immune response to SARS-CoV-2, indicating a recent or prior infection.
The new authorization is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988, the FDA said.
Upcoming Events
-
21Oct